Registration - In-house Organization

Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) / Association canadienne des pharmacies de quartier / Sandra Hanna, Chief Executive Officer

Registration Information
In-house Organization name: Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) / Association canadienne des pharmacies de quartier
Previous in-house organization names
Responsible Officer Name: Sandra Hanna, Chief Executive Officer 
Responsible Officer Change History
Initial registration start date: 2006-08-04
Registration status: Active
Registration Number: 944651-13462
Associated Communications

Total Number of Communication Reports: 4

Monthly communication reports in the last 6 months: 0

Version 1 of 20 (2006-08-04 to 2007-02-14)

Version 1 of 20 (2006-08-04 to 2007-02-14) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Organization Information

Organization: Canadian Association of Chain Drug Stores / Association canadienne des chaînes de pharmacies
45 SHEPPARD AVENUE EAST, SUITE 301
TORONTO, ON  M2N 5W9
Canada
Telephone number: 416-226-9100  Ext.: 226
Fax number:  
Responsible officer name and position during the period of this registration: Nadine Saby, President & CEO  
 
Description of the organization's activities: THE CANADIAN ASSOCIATION OF CHAIN DRUG STORES (CACDS) IS THE VOICE OF COMMUNITY PHARMACY IN CANADA. OUR MISSION IS TO ENSURE A STRONG CHAIN DRUG STORE SECTOR WHICH PROVIDES CANADIAN CONSUMERS WITH ACCESS TO HIGH QUALITY PRODUCTS AND HEALTH CARE SERVICES, BY CONTRIBUTING TO THE DEVELOPMENT OF INNOVATIVE HEALTH CARE SOLUTIONS, PROMOTING AND ENHANCING THE ROLE AND VALUE OF OUR CHAIN PHARMACY MEMBERS AND THEIR PHARMACISTS IN THE HEALTH CARE SYSTEM, ENSURING THAT GOVERNMENTS AND REGULATORS WHOSE DECISIONS AFFECT THE ECONOMIC VIABILITY OF CHAIN DRUG STORES UNDERSTAND OUR ISSUES AND MAKE BETTER USE OF THE INFRASTRUCTURE AVAILABLE IN MEMBER LOCATIONS AND WORKING WITH OUR SUPPLIER COMMUNITY TO INCREASE CONSUMER SATISFACTION THROUGH GREATER EFFICIENCY AND EFFECTIVENESS OF OUR SUPPLY CHAIN.
Organization's membership or classes of membership: CACDS RESPRESENTS 22 COMMUNITY CHAIN DRUG STORE ORGANIZATIONS, INCLUDING TRADITIONAL PHARMACIES AND GROCERY AND MASS MERCHANDISE OUTLETS WITH PHARMACIES. IN ADDITION OUR 180 ASSOCIATE MEMBERS INCLUDE PRODUCT AND SERVICE SUPPLIERS TO THE CHAIN DRUG STORE SECTOR.
 
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Organization

Name: Malek Allan
Position title: Vice President, Pharmacy
Public offices held: No
 
Name: Nancy Bagworth
Position title: Director, Communications
Public offices held: No
 
Name: Heather Croisier
Position title: Director, Industry Issues & Member Services
Public offices held: No
 
Name: Nadine Saby
Position title: President & CEO
Public offices held: No
 
Name: Lori Turik
Position title: Vice President, Public Policy
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Canadian Agency for Drugs and Technologies in Health, Citizenship and Immigration Canada, Finance Canada (FIN), Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, National Research Council (NRC), Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Revenue Canada (RC), Royal Canadian Mounted Police (RCMP), Solicitor General Canada (SGC), Treasury Board Of Canada Secretariat (TBS)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Consumer Issues, Employment and Training, Environment, Health, Immigration, Industry, Intellectual Property, Internal Trade, International Trade, Labour, Regional Development, Science and Technology, Small Business, Taxation and Finance
 
Subject Matter: Retrospective: CACDS HAS FOCUSED ON PRIMARY HEALTH CARE REFORM, EMERGENCY RESPONSE AND PREPAREDNESS, PUBLIC HEALTH AND SAFETY, HEALTH HUMAN RESOURCES (ESP PHARMACIST AND TECHNICIAN SHORTAGES), INTERNATIONAL PHARMACY GRADUATE PROGRAMS, NATIONAL PHARMACEUTICAL STRATEGY, AND SUPPORTING E-HEALTH INITIATIVES.
Subject Matter: Prospective: CACDS WILL CONTINUE TO FOCUS ON PHARMACY INTEGRATION INTO PRIMARY HEALTH CARE DELIVERY SYSTEMS, E-HEALTH INITIATIVES (ESPECIALLY NEED FOR PAN-CANADIAN STANDARDS), EFFECTIVE REGULATIONS (SMART REGULATIONS, HEALTH CANADA LEGISLATIVE RENEWAL ETC), HUMAN RESOURCE SUFFICIENCY, AND SUPPLY CHAIN EFFICIENCY (RECALL AND WITHDRAWAL PROCEDURES, ELECTRONIC ORDERING OF CONTROLLED SUBSTANCES, ETC). OPPORTUNITIES TO PARTNER WITH GOVERNMENT ON HEALTH-ENHANCEMENT INITIATIVES SUCH AS PUBLIC HEALTH AGENCY OF CANADA'S SYNDROMIC SURVEILLANCE PILOT.
 
Details Regarding the Identified Subject Matter
Categories Description
Policy or Program CACDS is involved in government policy and economic initiatives that impact on the business of pharmacy.Policy examples: E-Health, Health Human Resources, National Pharmacy Strategy, Public Health & Safety and Emergency Response, and Supply Chain Efficiency. Program examples:Auditor General, Canada Health Infoway, Citizenship & Immigration, Finance Department, Health Canada, Human Resources & Skills Development Canada, Industry Canada, NIHB (Non-Insured Health Benefits), Patented Medicines Prices Review Board, andPrivy Council.
Legislative Proposal Legislation and regulations that impact on the business and practice of pharmacy. Specifically of interest are legislation and regulations regarding: Federal, Provincial and private drug plan policies and reimbursement; Pharmacy/retail operations such as: sampling, scanner accuracy, envionmental policy, tax and other economic policy; Drug safety and supply, controlled drugs and substances; Privacy of health information; Health Protection Legislative Renewal/Canada Health Protection Act; Smart Regulation Initiative; Natural health products; and Regulatory amendments to Food and Drugs Act, NHP Act, and Controlled Substances Act.




Date Modified: